Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-04-07

Clinical Trial Update: Vitamin D Replacement in Statin-Induced Myopathy [NA]

View source ↗

Summary

The clinical trial evaluating vitamin D replacement for statin-induced myopathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: HMG COA Reductase Inhibitor Adverse Reaction | NA | Status: WITHDRAWN